{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:16:28Z","timestamp":1794374188400,"version":"4.9.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005006","name":"Asan Institute for Life Sciences, Asan Medical Center","doi-asserted-by":"publisher","award":["2022IP0061-1"],"award-info":[{"award-number":["2022IP0061-1"]}],"id":[{"id":"10.13039\/501100005006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Patients with immune thrombocytopenia (ITP) have a risk of developing systemic lupus erythematosus (SLE). We sought to examine the clinical characteristics of patients with primary ITP who later developed SLE and identified the risk factors for the development of SLE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We retrospectively examined patients who were diagnosed with primary ITP at a tertiary hospital between August 2001 and November 2019. We compared the clinical characteristics according to the development of SLE. Logistic regression analysis was performed to identify the factors associated with the development of SLE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 130 patients with primary ITP, 10 (7.7%) were later diagnosed with SLE during follow-up (median, 30\u00a0months [IQR, 15.5\u2013105]). The presence of skin bleeding, organ bleeding, lymphocytopenia, anemia, and antinuclear antibody (ANA) positivity (\u2265\u20091:160) were more common among patients who later developed SLE than did those who did not develop SLE. Multivariate analysis showed that young age (&lt;\u200940\u00a0years; odds ratio [OR], 6.307 [95% confidence interval (CI), 1.114\u201334.908];<jats:italic>P<\/jats:italic>\u2009=\u20090.035), organ bleeding (OR, 13.672 [95% CI, 2.437\u201376.689];<jats:italic>P<\/jats:italic>\u2009=\u20090.003), and ANA positivity (1:160; OR, 6.638 [95% CI, 1.399\u201331.504];<jats:italic>P<\/jats:italic>\u2009=\u20090.017) were significantly associated with the development of SLE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Young age (&lt;\u200940\u00a0years), organ bleeding, and ANA positivity (\u2265\u20091:160) were risk factors for the development of SLE in patients with primary ITP. Close follow-up is needed to detect the development of SLE in patients with ITP and the abovementioned risk factors.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13075-022-02901-y","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T06:02:43Z","timestamp":1662444163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Prognostic factors for the development of systemic lupus erythematosus in patients with immune thrombocytopenia"],"prefix":"10.1186","volume":"24","author":[{"given":"Soo Min","family":"Ahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Ji","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Seon","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Gil","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Keun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seokchan","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,6]]},"reference":[{"key":"2901_CR1","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1056\/NEJMcp1810479","volume":"381","author":"N Cooper","year":"2019","unstructured":"Cooper N, Ghanima W. Immune thrombocytopenia. N Engl J Med. 2019;381:945\u201355.","journal-title":"N Engl J Med"},{"key":"2901_CR2","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMra071297","volume":"358","author":"A Rahman","year":"2008","unstructured":"Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med. 2008;358:929\u201339.","journal-title":"N Engl J Med"},{"key":"2901_CR3","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1136\/ard.2004.033100","volume":"64","author":"PD Ziakas","year":"2005","unstructured":"Ziakas PD, Giannouli S, Zintzaras E, Tzioufas AG, Voulgarelis M. Lupus thrombocytopenia: clinical implications and prognostic significance. Ann Rheum Dis. 2005;64:1366\u20139.","journal-title":"Ann Rheum Dis"},{"key":"2901_CR4","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1177\/0961203312438630","volume":"21","author":"M Jallouli","year":"2012","unstructured":"Jallouli M, Frigui M, Marzouk S, Snoussi M, Kechaou M, Kaddour N, et al. Clinical implications and prognostic significance of thrombocytopenia in Tunisian patients with systemic lupus erythematosus. Lupus. 2012;21:682\u20137.","journal-title":"Lupus"},{"key":"2901_CR5","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1177\/0961203320908932","volume":"29","author":"D Nikolopoulos","year":"2020","unstructured":"Nikolopoulos D, Kostopoulou M, Pieta A, Karageorgas T, Tseronis D, Chavatza K, et al. Evolving phenotype of systemic lupus erythematosus in Caucasians: low incidence of lupus nephritis, high burden of neuropsychiatric disease and increased rates of late-onset lupus in the \u2018Attikon\u2019 cohort. Lupus. 2020;29:514\u201322.","journal-title":"Lupus"},{"key":"2901_CR6","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/annrheumdis-2020-217356","volume":"79","author":"A Fanouriakis","year":"2020","unstructured":"Fanouriakis A, Bertsias G, Boumpas DT. Population-based studies in systemic lupus erythematosus: immune thrombocytopenic purpura or \u2018blood-dominant\u2019 lupus? Ann Rheum Dis. 2020;79:683\u20134.","journal-title":"Ann Rheum Dis"},{"key":"2901_CR7","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1177\/0961203315624557","volume":"25","author":"YH Lee","year":"2016","unstructured":"Lee YH, Bae SC. Association between interferon-\u03b3 +874 T\/A polymorphism and susceptibility to autoimmune diseases: a meta-analysis. Lupus. 2016;25:710\u20138.","journal-title":"Lupus"},{"key":"2901_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12865-014-0061-0","volume":"15","author":"PB McGarvey","year":"2014","unstructured":"McGarvey PB, Suzek BE, Baraniuk JN, Rao S, Conkright B, Lababidi S, et al. In silico analysis of autoimmune diseases and genetic relationships to vaccination against infectious diseases. BMC Immunol. 2014;15:61.","journal-title":"BMC Immunol"},{"key":"2901_CR9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2141.2007.06881.x","volume":"140","author":"R Sood","year":"2008","unstructured":"Sood R, Wong W, Gotlib J, Jeng M, Zehnder JL. Gene expression and pathway analysis of immune thrombocytopenic purpura. Br J Haematol. 2008;140:99\u2013103.","journal-title":"Br J Haematol"},{"key":"2901_CR10","first-page":"867","volume":"24","author":"M Mestanza-Peralta","year":"1997","unstructured":"Mestanza-Peralta M, Ariza-Ariza R, Cardiel MH, Alcocer-Varela J. Thrombocytopenic purpura as initial manifestation of systemic lupus erythematosus. J Rheumatol. 1997;24:867\u201370.","journal-title":"J Rheumatol"},{"key":"2901_CR11","first-page":"611","volume":"16","author":"J Balsalobre Aznar","year":"1999","unstructured":"Balsalobre Aznar J, Herr\u00e1ez Herrera P, PortaetEssam J, Torres Mart\u00edn C, Bermell Serrano JC, N\u00fa\u00f1ezL\u00f3pez R, et al. Idiopathic thrombocytopenic purpura as first manifestation of systemic lupus erythematosus lupus. An Med Interna. 1999;16:611\u20134.","journal-title":"An Med Interna."},{"key":"2901_CR12","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1136\/annrheumdis-2020-217013","volume":"79","author":"FX Zhu","year":"2020","unstructured":"Zhu FX, Huang JY, Ye Z, Wen QQ, Wei JC. Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study. Ann Rheum Dis. 2020;79:793\u20139.","journal-title":"Ann Rheum Dis"},{"key":"2901_CR13","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","volume":"113","author":"F Rodeghiero","year":"2009","unstructured":"Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113:2386\u201393.","journal-title":"Blood"},{"key":"2901_CR14","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1182\/blood-2012-07-442392","volume":"121","author":"F Rodeghiero","year":"2013","unstructured":"Rodeghiero F, Michel M, Gernsheimer T, Ruggeri M, Blanchette V, Bussel JB, et al. Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group. Blood. 2013;121:2596\u2013606.","journal-title":"Blood"},{"key":"2901_CR15","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.","journal-title":"Arthritis Rheum."},{"key":"2901_CR16","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29:288\u201391.","journal-title":"J Rheumatol"},{"key":"2901_CR17","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3109\/09537101003735564","volume":"21","author":"H Zhao","year":"2010","unstructured":"Zhao H, Li S, Yang R. Thrombocytopenia in patients with systemic lupus erythematosus: significant in the clinical implication and prognosis. Platelets. 2010;21:380\u20135.","journal-title":"Platelets"},{"key":"2901_CR18","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1182\/blood-2014-05-578336","volume":"124","author":"G Moulis","year":"2014","unstructured":"Moulis G, Palmaro A, Montastruc JL, Godeau B, Lapeyre-Mestre M, Sailler L. Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France. Blood. 2014;124:3308\u201315.","journal-title":"Blood"},{"key":"2901_CR19","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1001\/archinte.160.11.1630","volume":"160","author":"YC Cohen","year":"2000","unstructured":"Cohen YC, Djulbegovic B, Shamai-Lubovitz O, Mozes B. The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. Arch Intern Med. 2000;160:1630\u20138.","journal-title":"Arch Intern Med"},{"key":"2901_CR20","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1007\/s004640000355","volume":"15","author":"N Katkhouda","year":"2001","unstructured":"Katkhouda N, Grant SW, Mavor E, Friedlander MH, Lord RV, Achanta K, et al. Predictors of response after laparoscopic splenectomy for immune thrombocytopenic purpura. Surg Endosc. 2001;15:484\u20138.","journal-title":"Surg Endosc"},{"key":"2901_CR21","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/ejh.12839","volume":"98","author":"M Marangon","year":"2017","unstructured":"Marangon M, Vianelli N, Palandri F, Mazzucconi MG, Santoro C, Barcellini W, et al. Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long-term response. Eur J Haematol. 2017;98:371\u20137.","journal-title":"Eur J Haematol"},{"key":"2901_CR22","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1016\/S0140-6736(19)30546-X","volume":"393","author":"T Dorner","year":"2019","unstructured":"Dorner T, Furie R. Novel paradigms in systemic lupus erythematosus. Lancet. 2019;393:2344\u201358.","journal-title":"Lancet"},{"key":"2901_CR23","doi-asserted-by":"publisher","first-page":"e5565","DOI":"10.1097\/MD.0000000000005565","volume":"95","author":"Y Liu","year":"2016","unstructured":"Liu Y, Chen S, Sun Y, Lin Q, Liao X, Zhang J, et al. Clinical characteristics of immune thrombocytopenia associated with autoimmune disease: a retrospective study. Medicine (Baltimore). 2016;95:e5565.","journal-title":"Medicine (Baltimore)"},{"key":"2901_CR24","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1055\/s-0037-1613754","volume":"83","author":"JM Vantelon","year":"2000","unstructured":"Vantelon JM, Godeau B, Andr\u00e9 C, Bierling P. Screening for autoimmune markers is unnecessary during follow-up of adults with autoimmune thrombocytopenic purpura and no autoimmune markers at onset. Thromb Haemost. 2000;83:42\u20135.","journal-title":"Thromb Haemost"},{"key":"2901_CR25","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1177\/0961203308089429","volume":"17","author":"S Hong","year":"2008","unstructured":"Hong S, Lee J, Chi H, Lee C, Nah S, Kim Y, et al. Systemic lupus erythematosus complicated by acquired von Willebrand\u2019s syndrome. Lupus. 2008;17:846\u20138.","journal-title":"Lupus"},{"key":"2901_CR26","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/acr.22200","volume":"66","author":"N Jordan","year":"2014","unstructured":"Jordan N, Chaib A, Sangle S, Tungekar F, Sabharwal T, Abbs I, et al. Association of thrombotic microangiopathy and intimal hyperplasia with bleeding post\u2013renal biopsy in antiphospholipid antibody\u2013positive patients. Arthritis Care Res. 2014;66:725\u201331.","journal-title":"Arthritis Care Res"},{"key":"2901_CR27","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1177\/0961203317751048","volume":"27","author":"Y Sun","year":"2018","unstructured":"Sun Y, Sun I, Wang H, Yang A, Tsai C, Huang C, et al. Risk of complications of ultrasound-guided renal biopsy for adult and pediatric patients with systemic lupus erythematosus. Lupus. 2018;27:828\u201336.","journal-title":"Lupus"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02901-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-022-02901-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02901-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T16:25:44Z","timestamp":1701015944000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-022-02901-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,6]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2901"],"URL":"https:\/\/doi.org\/10.1186\/s13075-022-02901-y","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,6]]},"assertion":[{"value":"24 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Asan Medical Center (IRB number: 2020\u20131743). The requirement for informed consent was waived due to the retrospective design of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"213"}}